Therapeutic Class (Allergy):
Medicinal Ingredient: Cyproheptadine Hydrochloride USP. Non-medicinal Ingredients (alphabetically): Colloidal Silicon Dioxide, Lactose, Magnesium Stearate, Microcrystalline Cellulose, Pregelatinized Starch, Sodium Starch Glycolate.
This tablet is recommended for the symptomatic relief of allergic states generally responsive to antihistamines. Cyproheptadine has been observed to cause a small but significant increase in body weight of some adults and children who are underweight and in some patients. Following discontinuation of therapy there may be some weight loss but usually not to pretreatment levels.
Children: pms-Cyproheptadine Hydrochloride should be given to children only on the advice and direction of a physician. pms-Cyproheptadine Hydrochloride is not recommended for children under 2 years of age. 2 to 6 years: ½ tablet, 2 or 3 times daily (max. 2 tablets per day). 6 to 14 years: ½ to 1 tablet, 2 or 3 times daily (max. 4 tablets per day).
Adults: 1 to 1 ½ tablets, 3 or 4 times daily (max. 5 tablets per day). Prolonged usage should only be on the advice and direction of a physician. Never exceed the recommended dosage.
This product is to be used only on the advice of a physician.
pms-Cyproheptadine Hydrochloride must not be taken in the following circumstances:
- Patients with an allergy to Cyproheptadine
- During an acute asthmatic attack
- By nursing mothers
- By newborn or premature infants
- During pregnancy
- Patients with glaucoma
- Patients predisposed to urinary retention
- Patients with active peptic ulcer or a narrowing of the passage between the stomach and intestine
- Elderly weakened patients
- In conjunction with medicines known as monoamine oxidase inhibitors used to treat mental depression
In the event of an overdose, contact your physician or hospital at once. An overdose may lead to unconsciousness and possibly death. Some symptoms and findings of an overdose are convulsions, shortness of breath or troubled breathing, clumsiness or unsteadiness, hallucinations or severe drowsiness.
Warnings and precautions:
pms-Cyproheptadine Hydrochloride may impair alertness in some patients. Patients receiving this drug are cautioned against the operation of automobiles and other activities made hazardous by diminished alertness. This drug is more likely to cause dizziness, sedation and low blood pressure in elderly patients. In the young child, pms-Cyproheptadine Hydrochloride may occasionally produce excitation. Patients taking this drug are cautioned against the use of alcohol and tranquilizing drugs. A physician should be consulted under the following circumstances: patient develops unusual or troublesome symptoms; patient is taking other medication, or patient experiences severe loss of appetite. A low incidence of dry mouth, nervousness, faintness, headache, nausea, skin rashes, fatigue and diarrhea has been reported.
Store between 15°C and 30°C.
These products may not be suitable for everyone. Read the labels and follow the directions of use.
For additional information, contact us at 1-888-550-6060 or by email at email@example.com.